Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study
Highlights • 150 patients: randomised to phenytoin (50), valproate (50) and levetiracetam (50). • Phenytoin group: seizures were controlled in 68% with lorazepam + phenytoin. • Valproate group: seizures were controlled in 68% with lorazepam + valproate. • Levetiracetam group: seizures were controlle...
Gespeichert in:
Veröffentlicht in: | Epilepsy research 2015-08, Vol.114, p.52-58 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • 150 patients: randomised to phenytoin (50), valproate (50) and levetiracetam (50). • Phenytoin group: seizures were controlled in 68% with lorazepam + phenytoin. • Valproate group: seizures were controlled in 68% with lorazepam + valproate. • Levetiracetam group: seizures were controlled in 78% with lorazepam + levetiracetam. • Phenytoin, valproate, and levetiracetam are safe and equally efficacious. |
---|---|
ISSN: | 0920-1211 1872-6844 |
DOI: | 10.1016/j.eplepsyres.2015.04.013 |